IBC\’s Genome Editing Applications conference will showcase the most up-to-date therapeutic and biomedical applications emerging using CRISPRs, ZFNs, TALENs, AAVs and other genome engineering technologies. From validation of targeted cell lines and development of transgenic animal models to therapeutic uses in cell therapy, gene therapy and immunotherapy, this event will also highlight applications in drug target identification/validation and lead discovery and explore how these technologies are being used for whole-genome and functional screening as well as basic research applications.

Register Now to Build Up Your Drug Pipeline & R&D Programs. Plus:

• Discover the most cutting-edge therapeutic applications of genome editing
• Meet world-leaders in genome editing technologies and applications
• Find out which genome editing approach is best for your research application
• Learn to apply genome editing approaches to accelerate your drug discovery, screening and disease model development
• Get an in-depth report on technology advances, challenges and opportunities of CRISPR-Cas9 and other genome editing technologies
• Hear first-hand perspectives from the FDA & NIH on genome editing technologies

Register Now »Brochure Now Available
» Download Today!

Confirmed Keynote Speakers

Development and Applications of CRISPR-Cas9 for Genome Editing
Feng Zhang, Ph.D.
Investigator, McGovern Institute for Brain Research and Core Faculty Member, The Broad Institute of MIT and Harvard

Radical Genome Editing
George Church, Ph.D.
Robert Winthrop Professor of Genetics, Harvard Medical School and MIT Health Sciences and Technology

Hear an FDA Perspective in an Interactive Panel Discussion on Genome Editing
Jakob Reiser, Ph.D.
Principal Investigator, Gene Therapy Branch, Division of Cellular & Gene Therapies, OCTGT, CBER, FDA

» Download the Complete Brochure (PDF)